These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15080472)

  • 1. The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog.
    Meyer-Lindenberg A; Wohlfarth KM; Switzer EN
    Aust Vet J; 2003 Oct; 81(10):612-4. PubMed ID: 15080472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary blepharospasm: diagnosis and management.
    Defazio G; Livrea P
    Drugs; 2004; 64(3):237-44. PubMed ID: 14871168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Videonystagmography as a tool to assess blepharospasm before and after botulinum toxin injection.
    Casse G; Adenis JP; Sauvage JP; Robert PY
    Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1307-14. PubMed ID: 18581129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin and blink rate in patients with blepharospasm and increased blinking.
    Ferrazzano G; Conte A; Fabbrini G; Bologna M; Macerollo A; Defazio G; Hallett M; Berardelli A
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):336-40. PubMed ID: 24963123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
    Mezaki T; Kaji R; Brin MF; Hirota-Katayama M; Kubori T; Shimizu T; Kimura J
    Mov Disord; 1999 Nov; 14(6):1017-20. PubMed ID: 10584680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI; Shin HM; Lee SY; Lew H
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Essential blepharospasm : Practice-oriented therapy with botulinum toxin employing reduced treatment intervals].
    Wabbels B; Roggenkämper P
    Ophthalmologe; 2012 Jan; 109(1):45-53. PubMed ID: 22130729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of blepharospasm with botulinum toxin.
    Tsoy EA; Buckley EG; Dutton JJ
    Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
    Kocabeyoglu S; Sekeroglu HT; Mocan MC; Muz E; Irkec M; Sanac AS
    Eur J Ophthalmol; 2014; 24(6):830-4. PubMed ID: 24803156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.
    Boroojerdi B; Ferbert A; Schwarz M; Herath H; Noth J
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):111-4. PubMed ID: 9667571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ophthalmologic quiz. Enophthalmos and blepharospasm in a dog].
    Köstlin R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Nov; 26(6):389, 408-9. PubMed ID: 9857419
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
    Mauriello JA; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MC
    Br J Ophthalmol; 1996 Dec; 80(12):1073-6. PubMed ID: 9059273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.